跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
A-485
首页
药物
A-485
A-485
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
DNA polymerase variant and application thereof
US 10883091 B2
申请人: MGI TECH CO LTD
优先权: 2017
CN
EP
US
3 件公开
Novel Formulations of Fat-Soluble Active Ingredients with High Biovailability
US 2008299209 A1
申请人: BECK MARKUS
优先权: 2005
CN
US
3 件公开
USE OF CIRCULATING MICRORNA PROFILES FOR IDENTIFICATION OF BRCA1 OR BRCA2 MUTATIONS
EP 4706047 A2
申请人: DANA FARBER CANCER INST INC
优先权: 2023
EP
WO
2 件公开
Putative cytokinin receptor and methods for use thereof
US 9290777 B2
申请人: KUMAR PRAKASH PALLATHADKA
优先权: 2008
US
2 件公开
Herbicidal compositions
US 8586503 B2
申请人: HACKER ERWIN
优先权: 2008
US
2 件公开
Uses for prevention or treatment of brain diseases using microrna
US 10844380 B1
申请人: BIORCHESTRA CO LTD
优先权: 2019
US
2 件公开
Insect ligand-gated anion channels
EP 1136502 A1
申请人: BAYER AG
优先权: 2000
EP
Proprietary Chinese medicine for treating diabetes and nephrosis and preparing method thereof
CN 101167863 B
申请人: CHONGQING TRADITIONAL CHINESE MEDICINE INST
优先权: 2007
CN
Pichia pastoris-expressed bovine lactoferrin-derived antibacterial fragment BLfA and preparation method thereof
CN 102408480 A
申请人: FEED RES INST CAAS
优先权: 2010
CN
5% povidone iodine solution
CN 102475678 A
申请人: JIANGSU QINFEN PHARMACEUTICAL CO LTD
优先权: 2010
CN
第 1 / 4 页
上一页
下一页
药物
反馈